Pfizer
The case for Pfizer
I understand why investors don’t want to own Pfizer (PFE); there is little excitement in the stock.
Random thoughts, Stocks for the Long-Run, no more
Today I’ve caught up on my last three BusinessWeek podcasts, called “Story Behind the Story.” John Burns, BW’s editor, interviews the reporter who wrote this week’s cover story.
Pfizer: Blockbuster success is a double-edged sword
I wrote this article for FT in 2005, but after reading news on Pfizer it feels like I could have written it today.
